Australia markets closed

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
11,062.00+100.00 (+0.91%)
At close: 04:28PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 169.94B
Enterprise value 188.09B
Trailing P/E 36.07
Forward P/E 16.26
PEG ratio (5-yr expected) 0.88
Price/sales (ttm)4.69
Price/book (mrq)5.44
Enterprise value/revenue 4.11
Enterprise value/EBITDA 14.01

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 3-7.82%
S&P500 52-week change 325.65%
52-week high 312,392.00
52-week low 39,461.00
50-day moving average 310,302.68
200-day moving average 310,516.71

Share statistics

Avg vol (3-month) 32.97M
Avg vol (10-day) 31.98M
Shares outstanding 51.55B
Implied shares outstanding 61.56B
Float 81.54B
% held by insiders 10.18%
% held by institutions 150.56%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.28
Forward annual dividend yield 42.12%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 30.03%
5-year average dividend yield 42.52
Payout ratio 475.49%
Dividend date 3N/A
Ex-dividend date 422 Feb 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 13.00%
Operating margin (ttm)16.92%

Management effectiveness

Return on assets (ttm)6.60%
Return on equity (ttm)15.64%

Income statement

Revenue (ttm)45.81B
Revenue per share (ttm)29.58
Quarterly revenue growth (yoy)7.30%
Gross profit (ttm)N/A
EBITDA 15.01B
Net income avi to common (ttm)5.95B
Diluted EPS (ttm)3.02
Quarterly earnings growth (yoy)6.50%

Balance sheet

Total cash (mrq)5.86B
Total cash per share (mrq)3.78
Total debt (mrq)29.65B
Total debt/equity (mrq)75.70%
Current ratio (mrq)0.82
Book value per share (mrq)25.25

Cash flow statement

Operating cash flow (ttm)10.34B
Levered free cash flow (ttm)9.5B